Antitrust Law

September 14 : The Federal Trade Commission pledged criminal referrals and civil litigation for pharmaceutical executives that use a certain technique - known as ‘Orange Book fraud’ to lie about their patents and in turn block lower priced drugs. Orange Book fraud is costly. Know why certain asthma inhalers cost more than $100 apiece today vs just... See more

The Antitrust Division will hopefully respond with “No, your search engine was awesome, but it’s increasingly ad-filled crap. You’re too powerful, you’re too lazy, and America needs some real competition.”

But this Google trial? By far the most important moment was when Judge Mehta denied a third-party motion to broadcast a publicly accessible audio feed of the trial for fear that information Google wishes wouldn’t be disclosed become public. Indeed, Google lawyers have explicitly argued that the judge should avoid allowing documents to become public... See more

The changeover has been absolutely stark, and it’s accelerating. Many of my sources in the competition policy world are giving me the same message, which is that this is the most extraordinary month they have ever seen in antitrust.

There are the big fights, the cases against Google and Amazon, the suits against private equity and meat... See more